Hope Pharmaceuticals

Sodium Thiosulfate

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

Hope Pharmaceuticals

Sodium Thiosulfate HCPCS:

J0209

HCPCS Code Descriptor:

Injection, sodium thiosulfate (hope), 100 mg

Category:

J Code

Sodium Thiosulfate NDCs:

60267-0705-50

Primary Type:

Antidote

Generic/Specialty Status:

Single-Source

Package Type:

Route of Administration:

Intravenous

Sodium Thiosulfate CPT Codes:

Some of the most common CPT administration codes for 'buy and bill' drugs can be found at the following link:

Potential NDC Listing Errors:

We have not identified any potential errors with the NDCs mapped to this HCPCS code.

About Sodium Thiosulfate:

Sodium Thiosulfate is manufactured by Hope Pharmaceuticalsand aligned to the J Code: J0209. Sodium Thiosulfate is a Antidote medication administered via the Intravenous route of administration.

ACCESS PRICING AND MORE BY REGISTERING

J0209 Added Date:

April 1, 2024

J0209 Effective Date:

April 1, 2024

J0209 Termination Date:

HCPCS Active

We have not identified a manufacturer-published billing and coding guide for Sodium Thiosulfate
Sodium Thiosulfate patient assistance information can be found through Pedmark at the URL: https://www.pedmark.com/fennec-hears/
Sodium Thiosulfate prescribing information can be found at the link below:
Our team has not yet identified a source of side effect information for Sodium Thiosulfate.